العربية
New discovery of scientists about lung cancer Amgen announced that their new drug called LumKras has reduced the risk of disease progression in lung cancer patients by 34%. This drug, which was able to get FDA approval last year through an accelerated process, was introduced as an alternative to chemotherapy, but it was carried out […]